Cargando…

Uptake of the human papillomavirus vaccine in Kenya: testing the health belief model through pathway modeling on cohort data

BACKGROUND: Many studies investigate HPV vaccine acceptability, applying health behavior theories to identify determinants; few include real uptake, the final variable of interest. This study investigated the utility of the Health Belief Model (HBM) in predicting HPV vaccine uptake in Kenya, focusin...

Descripción completa

Detalles Bibliográficos
Autores principales: Vermandere, Heleen, van Stam, Marie-Anne, Naanyu, Violet, Michielsen, Kristien, Degomme, Olivier, Oort, Frans
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5111174/
https://www.ncbi.nlm.nih.gov/pubmed/27846857
http://dx.doi.org/10.1186/s12992-016-0211-7
_version_ 1782467816459337728
author Vermandere, Heleen
van Stam, Marie-Anne
Naanyu, Violet
Michielsen, Kristien
Degomme, Olivier
Oort, Frans
author_facet Vermandere, Heleen
van Stam, Marie-Anne
Naanyu, Violet
Michielsen, Kristien
Degomme, Olivier
Oort, Frans
author_sort Vermandere, Heleen
collection PubMed
description BACKGROUND: Many studies investigate HPV vaccine acceptability, applying health behavior theories to identify determinants; few include real uptake, the final variable of interest. This study investigated the utility of the Health Belief Model (HBM) in predicting HPV vaccine uptake in Kenya, focusing on the importance of promotion, probing willingness to vaccinate as precursor of uptake and exploring the added value of personal characteristics. METHODS: Longitudinal data were collected before and after a pilot HPV vaccination program in Eldoret among mothers of eligible girls (N = 255). Through pathway modeling, associations between vaccine uptake and the HBM constructs, willingness to vaccinate and adequate promotion were examined. Adequate promotion was defined as a personal evaluation of promotional information received. Finally, baseline cervical cancer awareness and socio-demographic variables were added to the model verifying their direct, mediating or moderating effects on the predictive value of the HBM. RESULTS: Perceiving yourself as adequately informed at follow-up was the strongest determinant of vaccine uptake. HBM constructs (susceptibility, self-efficacy and foreseeing father’s refusal as barrier) only influenced willingness to vaccinate, which was not correlated with vaccination. Baseline awareness of cervical cancer predicted uptake. CONCLUSIONS: The association between adequate promotion and vaccination reveals the importance of triggers beyond personal control. Adoption of new health behaviors might be more determined by organizational variables, such as promotion, than by prior personal beliefs. Assessing users’ and non-users’ perspectives during and after implementing a vaccination program can help identifying stronger determinants of vaccination behavior. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12992-016-0211-7) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5111174
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-51111742016-11-25 Uptake of the human papillomavirus vaccine in Kenya: testing the health belief model through pathway modeling on cohort data Vermandere, Heleen van Stam, Marie-Anne Naanyu, Violet Michielsen, Kristien Degomme, Olivier Oort, Frans Global Health Research BACKGROUND: Many studies investigate HPV vaccine acceptability, applying health behavior theories to identify determinants; few include real uptake, the final variable of interest. This study investigated the utility of the Health Belief Model (HBM) in predicting HPV vaccine uptake in Kenya, focusing on the importance of promotion, probing willingness to vaccinate as precursor of uptake and exploring the added value of personal characteristics. METHODS: Longitudinal data were collected before and after a pilot HPV vaccination program in Eldoret among mothers of eligible girls (N = 255). Through pathway modeling, associations between vaccine uptake and the HBM constructs, willingness to vaccinate and adequate promotion were examined. Adequate promotion was defined as a personal evaluation of promotional information received. Finally, baseline cervical cancer awareness and socio-demographic variables were added to the model verifying their direct, mediating or moderating effects on the predictive value of the HBM. RESULTS: Perceiving yourself as adequately informed at follow-up was the strongest determinant of vaccine uptake. HBM constructs (susceptibility, self-efficacy and foreseeing father’s refusal as barrier) only influenced willingness to vaccinate, which was not correlated with vaccination. Baseline awareness of cervical cancer predicted uptake. CONCLUSIONS: The association between adequate promotion and vaccination reveals the importance of triggers beyond personal control. Adoption of new health behaviors might be more determined by organizational variables, such as promotion, than by prior personal beliefs. Assessing users’ and non-users’ perspectives during and after implementing a vaccination program can help identifying stronger determinants of vaccination behavior. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12992-016-0211-7) contains supplementary material, which is available to authorized users. BioMed Central 2016-11-15 /pmc/articles/PMC5111174/ /pubmed/27846857 http://dx.doi.org/10.1186/s12992-016-0211-7 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Vermandere, Heleen
van Stam, Marie-Anne
Naanyu, Violet
Michielsen, Kristien
Degomme, Olivier
Oort, Frans
Uptake of the human papillomavirus vaccine in Kenya: testing the health belief model through pathway modeling on cohort data
title Uptake of the human papillomavirus vaccine in Kenya: testing the health belief model through pathway modeling on cohort data
title_full Uptake of the human papillomavirus vaccine in Kenya: testing the health belief model through pathway modeling on cohort data
title_fullStr Uptake of the human papillomavirus vaccine in Kenya: testing the health belief model through pathway modeling on cohort data
title_full_unstemmed Uptake of the human papillomavirus vaccine in Kenya: testing the health belief model through pathway modeling on cohort data
title_short Uptake of the human papillomavirus vaccine in Kenya: testing the health belief model through pathway modeling on cohort data
title_sort uptake of the human papillomavirus vaccine in kenya: testing the health belief model through pathway modeling on cohort data
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5111174/
https://www.ncbi.nlm.nih.gov/pubmed/27846857
http://dx.doi.org/10.1186/s12992-016-0211-7
work_keys_str_mv AT vermandereheleen uptakeofthehumanpapillomavirusvaccineinkenyatestingthehealthbeliefmodelthroughpathwaymodelingoncohortdata
AT vanstammarieanne uptakeofthehumanpapillomavirusvaccineinkenyatestingthehealthbeliefmodelthroughpathwaymodelingoncohortdata
AT naanyuviolet uptakeofthehumanpapillomavirusvaccineinkenyatestingthehealthbeliefmodelthroughpathwaymodelingoncohortdata
AT michielsenkristien uptakeofthehumanpapillomavirusvaccineinkenyatestingthehealthbeliefmodelthroughpathwaymodelingoncohortdata
AT degommeolivier uptakeofthehumanpapillomavirusvaccineinkenyatestingthehealthbeliefmodelthroughpathwaymodelingoncohortdata
AT oortfrans uptakeofthehumanpapillomavirusvaccineinkenyatestingthehealthbeliefmodelthroughpathwaymodelingoncohortdata